InsiderClue
Insiders · Profile

GILEAD SCIENCES, INC.

10% owner at ASSEMBLY BIOSCIENCES · 10% owner at Arcus Biosciences · 10% owner at Xilio Therapeutics · and 2 more. Filing since 31 Jan 2021. CIK 0000882095

ASMB ASSEMBLY BIOSCIENCES, INC. 10% owner · 3 trades RCUS Arcus Biosciences, Inc. 10% owner · 4 trades XLO Xilio Therapeutics, Inc. 10% owner · 2 trades KYTX Kyverna Therapeutics, Inc. 10% owner · 1 trade KLRS Kalaris Therapeutics, Inc. 10% owner · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
ASMB ASSEMBLY BIOSCIENCES, INC.
8 Aug 2025
10% owner
Bought
2,295,920
no price
104%
RCUS Arcus Biosciences, Inc.
18 Feb 2025
10% owner
Bought
1,363,636
$15.00M
4.5%
ASMB ASSEMBLY BIOSCIENCES, INC.
19 Dec 2024
10% owner
Bought
940,499
$20.10M
74.1%
XLO Xilio Therapeutics, Inc.
18 Dec 2024
10% owner
Bought
1,759,978
$1.83M
24.0%
ASMB ASSEMBLY BIOSCIENCES, INC.
17 Jun 2024
10% owner
Bought
179,500
no price
16.5%
XLO Xilio Therapeutics, Inc.
2 Apr 2024
10% owner
Bought
485,250
$368.79K
7.1%
KYTX Kyverna Therapeutics, Inc.
12 Feb 2024
10% owner
Bought
910,000
$20.02M
28.3%
RCUS Arcus Biosciences, Inc.
29 Jan 2024
10% owner
Bought
15,238,095
$320.00M
103%
RCUS Arcus Biosciences, Inc.
28 Jun 2023
10% owner
Bought
1,010,000
$19.45M
7.3%
KLRS Kalaris Therapeutics, Inc.
27 Jun 2023
10% owner
Bought
2,930,870
$10.99M
21.4%
RCUS Arcus Biosciences, Inc.
31 Jan 2021
10% owner
Bought
5,650,000
$220.35M
68.4%
11 decisions on file.